Swog.org
Access to Care May Reduce Cancer Disparities SWOG
WEBFounded in 1956, SWOG has run more than 1,400 cancer clinical trials enrolling nearly 215,000 patients. Unger and his team identified 36,995 patients who enrolled in 44 SWOG phase II or III treatment trials between 1986 and 2012. Patients hailed from all 50 states, and had 17 different cancer types, including acute myeloid leukemia, …
Actived: Just Now
URL: https://www.swog.org/news-events/news/2018/08/17/access-care-may-reduce-cancer-disparities
S/N1806 Toxicity Data: No Safety Concerns SWOG
WEBS/N1806 study team member Sameer G. Jhavar, MD, PhD, of Baylor Scott and White Health, of Temple, Texas, will present a safety report on 213 patients as an oral presentation at the 2022 annual meeting of the American Society for Radiation Oncology (ASTRO) in San Antonio on October 25. Study S/N1806 is supported by the National …
Trials Don't End Disparities for Poorest SWOG
WEBThe disparity persists.”. At SWOG, a cancer clinical trials group funded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), Unger is building a high-profile body of work that investigates the causes and effects of health disparities in cancer patients. In 2018, he published results of a study that showed
S1820 Shows Feasibility of Symptom Intervention Study SWOG
WEBThe S1820 study enrolled 117 participants who had undergone surgery for rectal cancer within the previous six to 24 months. Of these, 95 (81 percent) completed the run-in step, and 93 eligible participants were randomized to either the AIMS-RC intervention or the Healthy Living Education attention control. The primary efficacy endpoint in S1820
Clinical Research and Human Research Protection Training
WEBThis OHRP webinar explains how to determine whether an institution is considered engaged in human subjects’ research for the purpose of applying the Common Rule. (October 7, 2019) US Department of Health and Human Services Office of Research Integrity (ORI): Administrators and the Responsible Conduct of Research.
Quality Assurance & Audits SWOG
WEBVolunteer Auditor Program. The Quality Assurance Department is recruiting nurses and CRAs to serve as volunteer auditors for treatment audits. Nurses must have a minimum of 2 years of research experience and CRAs must have a minimum of 3 - 5 years of research experience. Auditors will work with a representative from the SWOG QA …
Our Advocates SWOG
WEBSWOG has two types of patient advocates - research advocates and community advocates. Research advocates are our clinical trial experts. They are assigned to a committee and are involved in all aspects of trial design and development, ensuring that the concerns of patients - medical, logistical, emotional, financial - are addressed and that patients …
ONJ Incidence Determined by S0702 SWOG
WEBA landmark study by researchers from the SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), has found that 2.8 percent of patients on average develop osteonecrosis of the jaw, or ONJ, within three years of starting a common …
Finasteride Safe, Long-Term Results Show SWOG
WEBFinasteride, a common hormone-blocking drug, reduces men's risk of getting prostate cancer without increasing their risk of dying from the disease. Initial study findings suggested there may be a link between use of the drug and a more lethal form of prostate cancer, but long-term follow-up shows that is not true.
Strong AYA Enrollment to SWOG Clinical Trials SWOG
WEBThe research looked at enrollment data from 444 cancer treatment trials conducted from 1996-2020 by the SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). The work has just been published in the journal Cancer.
A New Radiation Oncology Chair, as SWOG Does ASCO
WEBI'm excited to announce I have appointed Chul Soo Ha, MD, to chair SWOG's radiation oncology committee, effective yesterday! Dr. Ha is director of radiation oncology trials at the University of Texas Health Science Center at San Antonio’s Mays Cancer Center, is a Fellow of the American Society for Radiation Oncology (ASTRO), and has …
Nivo-AVD New Rx for Advanced Hodgkin Lymphoma SWOG
WEBA phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment with nivolumab, a PD-1 checkpoint inhibitor, and AVD chemotherapy (N-AVD) had a significantly lower risk of their cancer getting worse than patients treated with brentuximab vedotin, a monoclonal …
RxPONDER Results Published in NEJM SWOG
WEBResults from further analysis of RxPONDER data will be reported at the 2021 San Antonio Breast Cancer Symposium on December 8. The NEJM article is " 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer ." The S1007 RxPONDER study was sponsored by the NCI, part of the National Institutes of Health …
PATIENT CHART REVIEW
WEBReview of a patient chart involves the following: Review of the primary record to determine compliance to protocol requirements. Review of the primary record to determine adequate source documentation is available to support all reported data. Review of data collection forms to determine accurate reporting of research data.
Top Categories
Popular Searched
› Suncrest home health slater road
› Sdlc application in health care
› St francis healthcare employment
› Veterans access to healthcare
› Sierra health services insurance
› Global health in healthcare education
› Texas health presbyterian insights roundtable
› Arkansas bcbs health insurance
Recently Searched
› Importance of public health research
› Owensboro health financial assistance
› Hutchinson mental health treatment plan
› Printable equine health record
› Organisation health and safety responsibilities
› California teen health law chart
› Health department in new bern nc
› Optimal health solutions naperville